论文信息 - Venetoclax Added to Cladribine (CLAD) + Low Dose AraC (LDAC) Alternating with Azacitidine (AZA) Is Highly Active As Frontline Therapy in Older Patients with Newly Diagnosed Acute Myeloid Leukemia in a Phase 2 Study - 字舞流文

Venetoclax Added to Cladribine (CLAD) + Low Dose AraC (LDAC) Alternating with Azacitidine (AZA) Is Highly Active As Frontline Therapy in Older Patients with Newly Diagnosed Acute Myeloid Leukemia in a Phase 2 Study

K. Bhalla | G. Garcia-Manero | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | U. Popat | N. Pemmaraju | N. Jain | N. Short | A. Ferrajoli | M. Ohanian | M. Brandt | P. Reville | D. Hammond | K. Sasaki | A. Maiti | G. Montalban-Bravo | H. Kantarjian | C. Rausch | G. Issa | M. Konopleva | Rashmi Malla | Kelly Quagliato